{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:43:47Z","timestamp":1790696627370,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874320"],"award-info":[{"award-number":["81874320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81741146"],"award-info":[{"award-number":["81741146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31500646"],"award-info":[{"award-number":["31500646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017055","name":"National Natural Science Foundation of China-Shandong Joint Fund","doi-asserted-by":"crossref","award":["U1606403"],"award-info":[{"award-number":["U1606403"]}],"id":[{"id":"10.13039\/100017055","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017055","name":"National Natural Science Foundation of China-Shandong Joint Fund","doi-asserted-by":"crossref","award":["U1706210"],"award-info":[{"award-number":["U1706210"]}],"id":[{"id":"10.13039\/100017055","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2017MH013"],"award-info":[{"award-number":["ZR2017MH013"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Patchouli alcohol (PA) is a tricyclic sesquiterpene extracted from<jats:italic>Pogostemonis Herba<\/jats:italic>, which is a traditional Chinese medicine used for therapy of inflammatory diseases. Recent studies have shown that PA has various pharmacological activities, including anti-bacterial and anti-viral effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, the anti-influenza virus (IAV) activities and mechanisms were investigated both in vitro and in vivo. The inhibitory effects of PA against IAV in vitro were evaluated by plaque assay and immunofluorescence assay. The neuraminidase inhibition assay, hemagglutination inhibition (HI) assay, and western blot assay were used to explore the anti-viral mechanisms. The anti-IAV activities in vivo were determined by mice pneumonia model and HE staining.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results showed that PA significantly inhibited different IAV strains multiplication in vitro, and may block IAV infection through inactivating virus particles directly and interfering with some early stages after virus adsorption. Cellular PI3K\/Akt and ERK\/MAPK signaling pathways may be involved in the anti-IAV actions of PA. Intranasal administration of PA markedly improved mice survival and attenuated pneumonia symptoms in IAV infected mice, comparable to the effects of Oseltamivir.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Therefore, Patchouli alcohol has the potential to be developed into a novel anti-IAV agent in the future.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12985-019-1266-x","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T14:03:26Z","timestamp":1577109806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K\/Akt and ERK\/MAPK signaling pathways"],"prefix":"10.1186","volume":"16","author":[{"given":"Yunjia","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-0629","authenticated-orcid":false,"given":"Cui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"1266_CR1","first-page":"1647","volume-title":"Fields virology","author":"P Palese","year":"2007","unstructured":"Palese P, Shaw ML. Orthomyxoviridae . the viruses and their replication. In: Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1647\u2013740.","edition":"5"},{"key":"1266_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrmicro.2017.174","volume":"16","author":"RA Medina","year":"2018","unstructured":"Medina RA. 1918 influenza virus . 100 years on, are we prepared against the next influenza pandemic? Nat Rev Microbiol. 2018;16:61\u20132.","journal-title":"Nat Rev Microbiol"},{"key":"1266_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1073\/pnas.1617020114","volume":"114","author":"RU Kadam","year":"2017","unstructured":"Kadam RU, Wilson IA. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc Natl Acad Sci U S A. 2017;114:206\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1266_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jmii.2016.11.006","volume":"50","author":"K Takamatsu","year":"2017","unstructured":"Takamatsu K, Marumo S, Fukui M, Hata A. Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease. J Microbiol Immunol Infect. 2017;50:541\u20134.","journal-title":"J Microbiol Immunol Infect"},{"key":"1266_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1517\/14740330902840519","volume":"8","author":"P Schirmer","year":"2009","unstructured":"Schirmer P, Holodniy M. Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin Drug Saf. 2009;8:357\u201371.","journal-title":"Expert Opin Drug Saf"},{"key":"1266_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IDR.S105473","volume":"10","author":"M Hussain","year":"2017","unstructured":"Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M. Drug resistance in influenza A virus: the epidemiology and management. Infect Drug Resist. 2017;10:121\u201334.","journal-title":"Infect Drug Resist"},{"key":"1266_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1056\/NEJMp0900648","volume":"360","author":"A Moscona","year":"2009","unstructured":"Moscona A. Global transmission of oseltamivir-resistant influenza. N Engl J Med. 2009;360:953\u20136.","journal-title":"N Engl J Med"},{"key":"1266_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17512433.2017.1255550","volume":"10","author":"A Mc Mahon","year":"2017","unstructured":"Mc Mahon A, Martin-Loeches I. The pharmacological management of severe influenza infection - 'existing and emerging therapies'. Expert Rev Clin Pharmacol. 2017;10:81\u201395.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1266_CR9","first-page":"4850612","volume":"2017","author":"G Hu","year":"2017","unstructured":"Hu G, Peng C, Xie X, Zhang S, Cao X. Availability, pharmaceutics, security, pharmacokinetics, and pharmacological activities of patchouli alcohol. Evid Based Complement Alternat Med. 2017;2017:4850612.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1266_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0944-7113(99)80041-5","volume":"6","author":"Y Yang","year":"1999","unstructured":"Yang Y, Kinoshita K, Koyama K, Takahashi K, Tai T, Nunoura Y, Watanabe K. Anti-emetic principles of Pogostemon cablin (Blanco) Benth. Phytomedicine. 1999;6:89\u201393.","journal-title":"Phytomedicine."},{"key":"1266_CR11","doi-asserted-by":"crossref","first-page":"671741","DOI":"10.1093\/ecam\/nep183","volume":"2011","author":"TC Lu","year":"2011","unstructured":"Lu TC, Liao JC, Huang TH, Lin YC, Liu CY, Chiu YJ, Peng WH. Analgesic and anti-inflammatory activities of the methanol extract from Pogostemon cablin. Evid Based Complement Alternat Med. 2011;2011:671741.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1266_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ptr.5227","volume":"29","author":"XD Yu","year":"2015","unstructured":"Yu XD, Xie JH, Wang YH, Li YC, Mo ZZ, Zheng YF, Su JY, Liang YE, Liang JZ, Su ZR, Huang P. Selective antibacterial activity of patchouli alcohol against helicobacter pylori based on inhibition of urease. Phytother Res. 2015;29:67\u201372.","journal-title":"Phytother Res"},{"key":"1266_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11418-011-0550-x","volume":"66","author":"H Kiyohara","year":"2012","unstructured":"Kiyohara H, Ichino C, Kawamura Y, Nagai T, Sato N, Yamada H. Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth. J Nat Med. 2012;66:55\u201361.","journal-title":"J Nat Med"},{"key":"1266_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.intimp.2011.12.007","volume":"12","author":"YC Li","year":"2012","unstructured":"Li YC, Peng SZ, Chen HM, Zhang FX, Xu PP, Xie JH, He JJ, Chen JN, Lai XP, Su ZR. Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice. Int Immunopharmacol. 2012;12:294\u2013301.","journal-title":"Int Immunopharmacol"},{"key":"1266_CR15","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.3390\/molecules16086489","volume":"16","author":"H Wu","year":"2011","unstructured":"Wu H, Li B, Wang X, Jin M, Wang G. Inhibitory effect and possible mechanism of action of patchouli alcohol against influenza A (H2N2) virus. Molecules. 2011;16:6489\u2013501.","journal-title":"Molecules."},{"key":"1266_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.antiviral.2011.08.010","volume":"92","author":"W Wang","year":"2011","unstructured":"Wang W, Zhang P, Hao C, Zhang XE, Cui ZQ, Guan HS. In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antivir Res. 2011;92:237\u201346.","journal-title":"Antivir Res"},{"key":"1266_CR17","doi-asserted-by":"publisher","first-page":"40760","DOI":"10.1038\/srep40760","volume":"7","author":"W Wang","year":"2017","unstructured":"Wang W, Wu J, Zhang X, Hao C, Zhao X, Jiao G, Shan X, Tai W, Yu G. Inhibition of influenza A virus infection by fucoidan targeting viral neuraminidase and cellular EGFR pathway. Sci Rep. 2017;7:40760.","journal-title":"Sci Rep"},{"key":"1266_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"1266_CR19","doi-asserted-by":"publisher","first-page":"e21207","DOI":"10.1371\/journal.pone.0021207","volume":"6","author":"M Fukushi","year":"2011","unstructured":"Fukushi M, Ito T, Oka T, Kitazawa T, Miyoshi-Akiyama T, Kirikae T, Yamashita M, Kudo K. Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLoS One. 2011;6:e21207.","journal-title":"PLoS One"},{"key":"1266_CR20","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1021\/acs.jmedchem.6b00326","volume":"60","author":"W Wang","year":"2017","unstructured":"Wang W, Yin R, Zhang M, Yu R, Hao C, Zhang L, Jiang T. Boronic acid modifications enhance the anti-influenza A virus activities of novel quindoline derivatives. J Med Chem. 2017;60:2840\u201352.","journal-title":"J Med Chem"},{"key":"1266_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1128\/AAC.03659-14","volume":"59","author":"J Kindrachuk","year":"2015","unstructured":"Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH, et al. Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob Agents Chemother. 2015;59:1088\u201399.","journal-title":"Antimicrob Agents Chemother"},{"key":"1266_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/35060098","volume":"3","author":"S Pleschka","year":"2001","unstructured":"Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S. Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade. Nat Cell Biol. 2001;3:301\u20135.","journal-title":"Nat Cell Biol"},{"key":"1266_CR23","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1128\/JVI.01969-10","volume":"85","author":"N Kumar","year":"2011","unstructured":"Kumar N, Liang Y, Parslow TG, Liang Y. Receptor tyrosine kinase inhibitors block multiple steps of influenza A virus replication. J Virol. 2011;85:2818\u201327.","journal-title":"J Virol"},{"key":"1266_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2011.05.009","volume":"92","author":"R Pinto","year":"2011","unstructured":"Pinto R, Herold S, Cakarova L, Hoegner K, Lohmeyer J, Planz O, Pleschka S. Inhibition of influenza virus-induced NF-kappaB and Raf\/MEK\/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antivir Res. 2011;92:45\u201356.","journal-title":"Antivir Res"},{"issue":"6","key":"1266_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1462-5822.2009.01309.x","volume":"11","author":"C Ehrhardt","year":"2009","unstructured":"Ehrhardt C, Ludwig S. A new player in a deadly game: influenza viruses and the PI3K\/Akt signalling pathway. Cell Microbiol. 2009;11(6):863\u201371.","journal-title":"Cell Microbiol"},{"issue":"1","key":"1266_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41598-017-18308-8","volume":"8","author":"C Oh","year":"2018","unstructured":"Oh C, Ryoo J, Park K, Kim B, Daly MB, Cho D, Ahn K. A central role for PI3K-AKT signaling pathway in linking SAMHD1-deficiency to the type I interferon signature. Sci Rep. 2018;8(1):84.","journal-title":"Sci Rep"},{"key":"1266_CR27","doi-asserted-by":"publisher","first-page":"A110","DOI":"10.1016\/j.antiviral.2008.12.014","volume":"82","author":"DL Barnard","year":"2009","unstructured":"Barnard DL. Animal models for the study of influenza pathogenesis and therapy. Antivir Res. 2009;82:A110\u201322.","journal-title":"Antivir Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1266-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T02:25:36Z","timestamp":1722219936000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1266-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1266-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was approved by the Ethics Committee of Ocean University of China.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}